Sg3 Management, LLC Athira Pharma, Inc. Put Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$2.26 - $4.22 $39,549 - $73,850	-17,500 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$2.93 - $3.96 $51,275 - $69,300	17,500 New	17,500 $54,000
Q2 2022 Aug 15, 2022	BUY	$2.74 - $13.43 $27,400 - $134,300	10,000 Added 133.33%	17,500 $53,000
Q4 2021 Feb 15, 2022	BUY	$9.17 - $16.39 $68,775 - $122,925	7,500 New	7,500 $98,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.2M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.